Serum proteomic profiling reveals potential biomarkers for cutaneous malignant melanoma.
about
Evaluating biomarkers in melanoma.Serum CEACAM1 Elevation Correlates with Melanoma Progression and Failure to Respond to Adoptive Cell Transfer Immunotherapy.Advances in the proteomic discovery of novel therapeutic targets in cancer.More than apples and oranges--detecting cancer with a fruit fly's antennaProtein and non-protein biomarkers in melanoma: a critical update.Targeting Melanoma with Cancer-Killing Viruses.
P2860
Serum proteomic profiling reveals potential biomarkers for cutaneous malignant melanoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Serum proteomic profiling reveals potential biomarkers for cutaneous malignant melanoma.
@ast
Serum proteomic profiling reveals potential biomarkers for cutaneous malignant melanoma.
@en
type
label
Serum proteomic profiling reveals potential biomarkers for cutaneous malignant melanoma.
@ast
Serum proteomic profiling reveals potential biomarkers for cutaneous malignant melanoma.
@en
prefLabel
Serum proteomic profiling reveals potential biomarkers for cutaneous malignant melanoma.
@ast
Serum proteomic profiling reveals potential biomarkers for cutaneous malignant melanoma.
@en
P2093
P356
P1476
Serum proteomic profiling reveals potential biomarkers for cutaneous malignant melanoma
@en
P2093
Aurélie Du-Thanh
Bernard Guillot
Thierry Maudelonde
P356
10.5301/JBM.2011.8344
P577
2011-04-01T00:00:00Z